www.sec.gov/Archives/edgar/data/786620/0000786620-03-00 -
[Cached Version]
Published on: 4/16/2003
Last Visited: 4/18/2003
Audit Committee The Audit Committee consists of the two non-management directors, Lowell K. Anderson and Richard Gommermann.
...
Lowell K. Anderson (5) 50,000
...
Anderson and Mackey were each granted options to purchase 8,000, 24,000 and 24,000 shares of CIMETRIX INC's common stock at $2.50 per share, in January 1998, June 1998 and June 1999, respectively.
...
Anderson, Gommermann, and Mackey have not been nominated for re-election to the Board of Directors and their terms as Board members will expire when their successors are elected at the annual meeting, on May 10, 2003. (6) On April 10, 2003, Messrs.
...
The Board of Directors, including Lowell K. Anderson, Richard Gommermann, and Randall A. Mackey, each of whom is an outside director, reviewed and approved the compensation and fringe benefits for CIMETRIX INC's officers.
...
Stock options are granted under the plan by the Board of Directors, including at least a majority vote by the disinterested members of the board who are currently Lowell K. Anderson, Richard Gommermann, and Randall A. Mackey.
...
Based solely on its review of the copies of Forms 3, 4, and 5 received with respect to fiscal year 2002, or written representations from certain reporting persons, CIMETRIX INC believes that all filing requests applicable to its directors, officers and greater than 10% beneficial owners were complied with, except that (i) Dr. Lowell K. Anderson, Richard Gommermann, Joe K. Johnson and Randall A. Mackey, directors of CIMETRIX INC, through an oversight, each filed a late Form 4 reporting the receipt of stock options; and (ii) Robert H. Reback, David P. Faulkner, Dr. Steven K. Sorensen, Michael D. Feaster, officers of the Company, through an oversight, each filed a late Form 4 reporting the receipt of stock options.
...
The address for Dr. Anderson is 2848 North Foothill Drive, Provo, Utah 84604.
...
(3) Includes 155,332 shares of common stock which Dr. Anderson has the right to acquire within 60 days upon the exercise of stock options.